ISSN:2167-7964

OMICS Journal of Radiology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Image Article   
  • OMICS J Radiol 2022, Vol 11(5): 382
  • DOI: 10.4172/2167-7964.1000382

Imaging and Radiation Therapy for Meningioma

Payal Patel*
Department of Health Science and Radiology, University of Botswana, Botswana
*Corresponding Author: Payal Patel, Department of Health Science and Radiology, University of Botswana, Botswana, Email: Payal_p@gmail.com

Received: 02-May-2022 / Manuscript No. roa-22-64827 / Editor assigned: 04-May-2022 / PreQC No. roa-22-64827 (PQ) / Reviewed: 18-May-2022 / QC No. roa-22-64827 / Revised: 20-May-2022 / Manuscript No. roa-22-64827 (R) / Published Date: 27-May-2022 DOI: 10.4172/2167-7964.1000382

Image Article

Radiation therapy can be an essential therapy for meningioma, or it tends to be directed after a medical procedure to destroy any abnormal cells that remain. During radiation therapy, high-energy beams are aimed at a tumor to damage the DNA inside its abnormal cells. This can assist with preventing the tumor cells from separating; it can likewise make existing cells to self-destruct. Tumors frequently shrivel after radiation therapy, which helps reduce pressure on the brain or spinal cord. This in turn can assist with mitigating side effects.

Meningiomas are characterized morphologically by the World Health Organization (WHO) evaluating plan into three categories [1]. While most meningiomas are harmless or grade I the affinity of certain subtypes to repeat following treatment makes a pathological course that can prompt a range of malignant disease.

The objective of medical procedure is to securely resect the tumor and acquire a diagnosis and pathological grade. Ensuing radiation therapy relies upon the degree of resection and pathological qualities. Patients holding on to either WHO grade II or III meningiomas have higher recurrence rates differing between 29-52 and 50-94% respectively [2]. This might be expected partially to parenchymal invasion or the aggressiveness of residual tumor cells. Higher recurrence rates correlate with decreased overall survival (Figure 1).

radiology-Thoraco-Radiation

Figure 1: Radiation Induced meningiomas.

Diagnosis

A Meningioma can be difficult to diagnose in light of the fact that the tumor is often slow growing. Side effects of a meningioma may likewise be unobtrusive and mistaken with other medical issue or written off as ordinary indications of aging.

If your provider suspects a meningioma, you might be alluded to a doctor who specializes in neurological conditions (neurologist).

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
  2. Indexed at, Google Scholar, Crossref

  3. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, et al. (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64: 56-60.
  4. Indexed at, Google Scholar, Crossref

Citation: Patel P (2022) Imaging and Radiation Therapy for Meningioma. OMICS J Radiol 11: 382. DOI: 10.4172/2167-7964.1000382

Copyright: © 2022 Patel P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top